.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,190,109

« Back to Dashboard

Details for Patent: 7,190,109

Title:Illuminator for photodynamic therapy
Abstract: An apparatus and method for photodynamic therapy or photodynamic diagnosis using an illuminator comprising a plurality of light sources generally conforming to a contoured surface and irradiating the contoured surface with substantially uniform intensity visible light. The light sources may comprise generally U-shaped fluorescent tubes that are driven by electronic ballasts. Adjustment of the ballast voltage controls the output power of the tubes. The tubes are supported by a sheet-metal or plastic housing and are covered by a polycarbonate shield which directs cooling airflow within the unit and prevents glass-patient contact in the event of tube breakage. An aluminum reflector located behind the tubes increases both the output irradiance and the uniformity of the output distribution. The spacing of the U-shaped tubes is varied to increase the output at the edges of the illuminator to make the output more uniform. Also, different portions of the tubes are cooled at different amounts, to improve uniformity. A light sensor monitors output from the U-shaped tubes to provide a signal for adjusting the output from the tubes.
Inventor(s): Lundahl; Scott (Lexington, MA), Kozodoy; Rebecca (Randolph, MA), Carroll; Ronald (Hingham, MA), Leppelmeier; Elton (Highland Heights, OH)
Assignee: Dusa Pharmaceuticals, Inc. (Toronto, CA)
Filing Date:Jan 13, 2004
Application Number:10/755,318
Claims:1. An illuminator for treating or diagnosing a patient, comprising: at least one light source, comprising a phosphor which emits light in the blue region, configured to illuminate the patient to treat or diagnose a dermatological condition, wherein the spectral output of the at least one light source substantially matches the absorption spectrum of protoporphyrin IX.

2. An illuminator as set forth in claim 1, wherein the at least one light source has a peak wavelength near 417 nm.

3. An illuminator as set forth in claim 1, wherein the light source comprises a fluorescent lamp.

4. An illuminator for treating or diagnosing a patient, comprising: at least one light source, comprising a phosphor which emits light in the blue region, configured to illuminate the patient to treat or diagnose a dermatological condition, wherein the light is substantially entirely limited to the blue region of the spectrum, wherein the spectral output of the at least one light source substantially matches the absorption spectrum of protoporphyrin IX.

5. An illuminator as set forth in claim 4, wherein the at least one light source has a peak wavelength near 417 nm.

6. An ilhuninator as set forth in claim 4, wherein the light source comprises a fluorescent lamp.

7. An illuminator for treating or diagnosing a patient, comprising: at least one light source, comprising a Europium doped phosphor, configured to illuminate the patient to treat or diagnose a dermatological condition, wherein the spectral output of the at least one light source substantially matches the absorption spectrum of protoporphyrin IX.

8. An illuminator as set forth in claim 7, wherein the Europium doped phosphor comprises a Europium doped Strontium phosphate.

9. An illuminator as set forth in claim 7, wherein the Europium doped phosphor comprises Sr.sub.2P.sub.2O.sub.7:Eu.

10. An illuminator as set forth in claim 7, wherein the at least one light source has a peak wavelength near 417 nm.

11. An illuminator as set forth in claim 7, wherein the light source comprises a fluorescent lamp.

12. An illuminator for treating or diagnosing a patient, comprising: at least one light source, comprising a Europium doped phosphor; configured to illuminate the patient to treat or diagnose a dermatological condition, wherein the light source is configured to illuminate the patient with substantially uniform intensity blue light, wherein the spectral output of the at least one light source substantially matches the absorption spectrum of protoporphyrin IX.

13. An illuminator for treating or diagnosing a patient, comprising: at least one light source, comprising a Europium doped phosphor, configured to illuminate the patient to treat or diagnose a dermatological condition, wherein at least part of the at least one light source is a curved tube, wherein the spectral output of the at least one light source substantially matches the absorption spectrum of protoporphyrin IX.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc